Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regulus Therapeutics Inc (NASDAQ:RGLS)

2.53
Delayed Data
As of 11:31am ET
 -0.125 / -4.72%
Today’s Change
2.13
Today|||52-Week Range
10.18
-71.04%
Year-to-Date
No recent news for Regulus Therapeutics Inc.

Today’s Trading

Previous close2.65
Today’s open2.60
Day’s range2.50 - 2.63
Volume104,241
Average volume (3 months)411,706
Market cap$140.2M
Dividend yield--
Data as of 11:31am ET, 12/08/2016

Growth & Valuation

Earnings growth (last year)+16.28%
Earnings growth (this year)-40.12%
Earnings growth (next 5 years)--
Revenue growth (last year)+170.69%
P/E ratioNM
Price/Sales21.60
Price/Book1.12

Competitors

 Today’s
change
Today’s
% change
AKAOAchaogen Inc+0.06+1.19%
XENEXenon Pharmaceutical...0.000.00%
GLYCGlycoMimetics Inc+0.01+0.16%
ATHXAthersys Inc+0.01+0.63%
Data as of 11:45am ET, 12/08/2016

Financials

Next reporting dateFebruary 22, 2017
EPS forecast (this quarter)-$0.37
Annual revenue (last year)$20.8M
Annual profit (last year)-$55.7M
Net profit margin-268.55%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Paul C. Grint
COO, Principal Financial &
Accounting Officer
Joseph P. Hagan
Corporate headquarters
San Diego, California

Forecasts


Search for Jobs